This inventor holds 2 USPTO granted patents. Top assignee: Wisconsin Alumni Research Foundation. Active years: 1997-1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997-1999
Title: Yvonne M Angell: Innovator in Immunosuppressive and Immunostimulatory Agents
Introduction
Yvonne M Angell is a prominent inventor based in Madison, WI (US). She has made significant contributions to the field of immunology through her innovative research and development of novel compounds. With a total of 2 patents, her work focuses on the synthesis of immunosuppressive and immunostimulatory agents.
Latest Patents
Yvonne's latest patents include groundbreaking methods for the solid-phase synthesis of immunosuppressive agents. One of her notable inventions relates to cyclosporin analogs, specifically methods for the solid-phase synthesis and on-resin cyclization of these compounds. The techniques she developed utilize specific solvent, temperature, and washing conditions to facilitate the efficient on-resin cyclization of sterically hindered compounds, such as analogs of cyclosporin A. Additionally, she has worked on compositions and methods for synthesizing novel analogs of cyclosporin A, which are utilized as immunostimulatory agents.
Career Highlights
Yvonne M Angell is associated with the Wisconsin Alumni Research Foundation, where she continues to advance her research. Her work has garnered attention for its potential applications in medical therapies, particularly in the fields of immunology and pharmacology.
Collaborations
Throughout her career, Yvonne has collaborated with esteemed colleagues, including Daniel H Rich and Prakash Raman. These partnerships have contributed to the success and impact of her research endeavors.
Conclusion
Yvonne M Angell stands out as an influential inventor in the realm of immunology, with her innovative patents paving the way for advancements in immunosuppressive and immunostimulatory therapies. Her contributions continue to inspire future research in this vital field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
